Firmenbeschreibung
Merck & Co. Inc. ist ein forschungsorientiertes, globales Pharmaunternehmen, das ein breites Sortiment an neuartigen Medikamenten, Impfstoffen und biologischen Therapeutika erforscht, entwickelt, produziert und vermarktet. Das Angebot richtet sich vorwiegend an Krankenhäuser, Apotheken, Einzelhändler, Versicherungen, Regierungsverwaltungen oder institutionelle Einrichtungen aus dem Gesundheitswesen. Des Weiteren bietet Merck & Co. nicht-verschreibungspflichtige Medikamente, Produkte für die Fußpflege und Sonnenschutzmittel sowie Gesundheitsprodukte für Tiere an. Dabei bedient sich das Unternehmen der Biotechnologie, der Genforschung und der Gentherapie. Schwerpunkte sind die Behandlung von Allergien, Atemwegserkrankungen, Infektionskrankheiten, Krebs, Herz- und Kreislauferkrankungen, Erkrankungen des zentralen Nervensystems sowie Hautkrankheiten.
KeyData
| endOfFinancialYear: | 31.12.2023 00:00 |
| stockholderStructure: | Vanguard Group Inc (9.66%),Blackrock Inc. (7.97%),State Street Corp (4.61%),Wellington Management Group Llp (3.38%),Geode Capital Management, Llc (2.19%),Fmr Llc (1.69%),Morgan Stanley (1.58%),Bank Of America Corp /De/ (1.5%),Charles Schwab Investment Management Inc (1.45%),Price T Rowe Associates Inc /Md/ (1.19%) |
| sharesOutstanding: | 2529635645.0000 |
| ceo: | Robert M. Davis |
| board: | Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Michael A. Klobuchar, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary, Dean Y. Li, M.D., Ph.D., Chirfi Guindo, Betty Larson |
| supervisoryBoard: | Robert M. Davis, Thomas H. Glocer, Risa J. Lavizzo-Mourey, M.D., Stephen L. Mayo, Ph.D., Paul B. Rothman, M.D., Patricia F. Russo, Christine E. Seidman, M.D., Inge G. Thulin, Kathy J. Warden, Peter C. Wendell, Mary Ellen Coe, Pamela J. Craig, Douglas M. Baker |
| countryID: | 20 |
| freeFloat: | 83.8400 |
| faceValue: | 0.5000 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | USA |
| countryName: | USA |
Kontakt
| phone: | +1-732-594-1468 |
| email: | investor_relations@merck.com |
| irWebSite: | https://www.merck.com/investor-relations/ |
Adresse
| street: | 126 East Lincoln Avenue |
| city: | Rahway, NJ 07065 USA |
| phone: | +1-908-740-4000 |
| webSite: | www.merck.com |
Finanzen (kurz)
| year: | 2021 | cash: | 8096.0000 |
| balanceSheetTotal: | 105694.0000 | liabilities: | 67437.0000 |
| shareCapital: | 1788.0000 | totalShareholdersEquity: | 38257.0000 |
| sales: | 48704.0000 | incomeBeforeTaxes: | 13879.0000 |
| netIncome: | 13049.0000 | cashFlow: | 14.0000 |
| employees: | 68000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2022 | cash: | 12694.0000 |
| balanceSheetTotal: | 109160.0000 | liabilities: | 63102.0000 |
| shareCapital: | 1788.0000 | totalShareholdersEquity: | 46058.0000 |
| sales: | 59283.0000 | incomeBeforeTaxes: | 16444.0000 |
| netIncome: | 14519.0000 | cashFlow: | 4606.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 6841.0000 |
| balanceSheetTotal: | 106675.0000 | liabilities: | 69040.0000 |
| shareCapital: | 1788.0000 | totalShareholdersEquity: | 37635.0000 |
| sales: | 60115.0000 | incomeBeforeTaxes: | 1889.0000 |
| netIncome: | 365.0000 | cashFlow: | -5864.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 8096.0000 |
| balanceSheetTotal: | 105694.0000 |
| liabilities: | 67437.0000 |
| shareCapital: | 1788.0000 |
| totalShareholdersEquity: | 38257.0000 |
| sales: | 48704.0000 |
| incomeBeforeTaxes: | 13879.0000 |
| netIncome: | 13049.0000 |
| cashFlow: | 14.0000 |
| employees: | 68000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 12694.0000 |
| balanceSheetTotal: | 109160.0000 |
| liabilities: | 63102.0000 |
| shareCapital: | 1788.0000 |
| totalShareholdersEquity: | 46058.0000 |
| sales: | 59283.0000 |
| incomeBeforeTaxes: | 16444.0000 |
| netIncome: | 14519.0000 |
| cashFlow: | 4606.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 6841.0000 |
| balanceSheetTotal: | 106675.0000 |
| liabilities: | 69040.0000 |
| shareCapital: | 1788.0000 |
| totalShareholdersEquity: | 37635.0000 |
| sales: | 60115.0000 |
| incomeBeforeTaxes: | 1889.0000 |
| netIncome: | 365.0000 |
| cashFlow: | -5864.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 109160.0000 | cash: | 12694.0000 |
| currentAssets: | 35722.0000 | fixedAssets: | 73438.0000 |
| liabilities: | 24239.0000 | totalLiabilitiesEquity: | 109160.0000 |
| totalShareholdersEquity: | 46058.0000 | property: | 21422.0000 |
| intangibleAssets: | 20269.0000 | longTermInvestments: | 1015.0000 |
| inventories: | 5911.0000 | accountsReceivable: | 9450.0000 |
| accountsPayable: | 4264.0000 | liabilitiesTotal: | 63102.0000 |
| longTermDebt: | 28745.0000 | shortTermDebt: | 1946.0000 |
| minorityInterests: | 67.0000 | commonStock: | 1788.0000 |
| sales: | 59283.0000 | depreciation: | 3885.0000 |
| netIncome: | 14519.0000 | incomeInterest: | -805.0000 |
| investments: | 13548.0000 | incomeTaxes: | 1918.0000 |
| costGoodsSold: | 17411.0000 | grossProfit: | 41872.0000 |
| minorityInterestsProfit: | 7.0000 | cashFlow: | 19095.0000 |
| cashFlowInvesting: | -4960.0000 | cashFlowFinancing: | -9119.0000 |
| cashFlowTotal: | 4606.0000 | accountingStandard: | US GAAP |
| equityRatio: | 42.1931 | debtEquityRatio: | 0.6664 |
| liquidityI: | 0.5237 | liquidityII: | 0.9136 |
| netMargin: | 24.4910 | grossMargin: | 70.6307 |
| cashFlowMargin: | 32.2099 | ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 35.7028 |
| preTaxROA: | 15.0641 | roe: | 31.5233 |
| roa: | 13.3007 | netIncomeGrowth: | 11.2652 |
| revenuesGrowth: | 21.7210 | taxExpenseRate: | 11.6638 |
| equityTurnover: | 1.2871 | epsBasic: | 5.7300 |
| epsDiluted: | 5.7100 | epsBasicGrowth: | 11.0465 |
| shareCapital: | 1788.0000 | incomeBeforeTaxes: | 16444.0000 |
| priceEarningsRatioCompany: | 19.3630 | priceCashFlowRatio: | 14.7503 |
| dividendYield: | 2.5237 | bookValuePerShare: | 18.1431 |
| marketCap: | 281656834213.6500 | earningsYield: | 5.1645 |
| pegRatio: | 1.7529 | cashFlowPerShare: | 7.5219 |
| netAssetsPerShare: | 18.1695 | priceBookValueRatio: | 6.1153 |
| dividendsPerShare: | 2.8000 | priceEarningsRatio: | 19.3992 |
| netEarningsPerShare: | 5.7193 | currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 106675.0000 | cash: | 6841.0000 |
| currentAssets: | 32168.0000 | fixedAssets: | 74507.0000 |
| liabilities: | 25694.0000 | totalLiabilitiesEquity: | 106675.0000 |
| totalShareholdersEquity: | 37635.0000 | property: | 23051.0000 |
| intangibleAssets: | 18011.0000 | longTermInvestments: | 252.0000 |
| inventories: | 6358.0000 | accountsReceivable: | 10349.0000 |
| accountsPayable: | 3922.0000 | liabilitiesTotal: | 69040.0000 |
| longTermDebt: | 33683.0000 | shortTermDebt: | 1372.0000 |
| minorityInterests: | 54.0000 | commonStock: | 1788.0000 |
| sales: | 60115.0000 | depreciation: | 3844.0000 |
| netIncome: | 365.0000 | incomeInterest: | -781.0000 |
| investments: | 30531.0000 | incomeTaxes: | 1512.0000 |
| costGoodsSold: | 16126.0000 | grossProfit: | 43989.0000 |
| minorityInterestsProfit: | 12.0000 | cashFlow: | 13006.0000 |
| cashFlowInvesting: | -14083.0000 | cashFlowFinancing: | -4810.0000 |
| cashFlowTotal: | -5864.0000 | accountingStandard: | US GAAP |
| equityRatio: | 35.2801 | debtEquityRatio: | 0.9314 |
| liquidityI: | 0.2662 | liquidityII: | 0.6690 |
| netMargin: | 0.6072 | grossMargin: | 73.1747 |
| cashFlowMargin: | 21.6352 | ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 5.0193 |
| preTaxROA: | 1.7708 | roe: | 0.9698 |
| roa: | 0.3422 | netIncomeGrowth: | -97.4861 |
| revenuesGrowth: | 1.4034 | taxExpenseRate: | 80.0424 |
| equityTurnover: | 1.5973 | epsBasic: | 0.1400 |
| epsDiluted: | 0.1400 | epsBasicGrowth: | -97.5567 |
| shareCapital: | 1788.0000 | incomeBeforeTaxes: | 1889.0000 |
| priceEarningsRatioCompany: | 778.7143 | priceCashFlowRatio: | 21.2293 |
| dividendYield: | 2.7151 | bookValuePerShare: | 14.8600 |
| marketCap: | 276108834925.4400 | earningsYield: | 0.1284 |
| pegRatio: | -7.9822 | cashFlowPerShare: | 5.1353 |
| netAssetsPerShare: | 14.8813 | priceBookValueRatio: | 7.3365 |
| dividendsPerShare: | 2.9600 | priceEarningsRatio: | 756.4626 |
| netEarningsPerShare: | 0.1441 | currency: | USD |
| year: | 2024 | priceEarningsRatioCompany: | 728.5714 |
| priceCashFlowRatio: | 19.8623 | dividendYield: | 2.9020 |
| bookValuePerShare: | 14.8600 | marketCap: | 258022835790.0000 |
| earningsYield: | 0.1373 | pegRatio: | -7.4682 |
| cashFlowPerShare: | 5.1353 | netAssetsPerShare: | 14.8600 |
| priceBookValueRatio: | 6.8641 | priceEarningsRatio: | 707.7525 |
| netEarningsPerShare: | 0.1441 | currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 109160.0000 |
| cash: | 12694.0000 |
| currentAssets: | 35722.0000 |
| fixedAssets: | 73438.0000 |
| liabilities: | 24239.0000 |
| totalLiabilitiesEquity: | 109160.0000 |
| totalShareholdersEquity: | 46058.0000 |
| property: | 21422.0000 |
| intangibleAssets: | 20269.0000 |
| longTermInvestments: | 1015.0000 |
| inventories: | 5911.0000 |
| accountsReceivable: | 9450.0000 |
| accountsPayable: | 4264.0000 |
| liabilitiesTotal: | 63102.0000 |
| longTermDebt: | 28745.0000 |
| shortTermDebt: | 1946.0000 |
| minorityInterests: | 67.0000 |
| commonStock: | 1788.0000 |
| sales: | 59283.0000 |
| depreciation: | 3885.0000 |
| netIncome: | 14519.0000 |
| incomeInterest: | -805.0000 |
| investments: | 13548.0000 |
| incomeTaxes: | 1918.0000 |
| costGoodsSold: | 17411.0000 |
| grossProfit: | 41872.0000 |
| minorityInterestsProfit: | 7.0000 |
| cashFlow: | 19095.0000 |
| cashFlowInvesting: | -4960.0000 |
| cashFlowFinancing: | -9119.0000 |
| cashFlowTotal: | 4606.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 42.1931 |
| debtEquityRatio: | 0.6664 |
| liquidityI: | 0.5237 |
| liquidityII: | 0.9136 |
| netMargin: | 24.4910 |
| grossMargin: | 70.6307 |
| cashFlowMargin: | 32.2099 |
| ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 35.7028 |
| preTaxROA: | 15.0641 |
| roe: | 31.5233 |
| roa: | 13.3007 |
| netIncomeGrowth: | 11.2652 |
| revenuesGrowth: | 21.7210 |
| taxExpenseRate: | 11.6638 |
| equityTurnover: | 1.2871 |
| epsBasic: | 5.7300 |
| epsDiluted: | 5.7100 |
| epsBasicGrowth: | 11.0465 |
| shareCapital: | 1788.0000 |
| incomeBeforeTaxes: | 16444.0000 |
| priceEarningsRatioCompany: | 19.3630 |
| priceCashFlowRatio: | 14.7503 |
| dividendYield: | 2.5237 |
| bookValuePerShare: | 18.1431 |
| marketCap: | 281656834213.6500 |
| earningsYield: | 5.1645 |
| pegRatio: | 1.7529 |
| cashFlowPerShare: | 7.5219 |
| netAssetsPerShare: | 18.1695 |
| priceBookValueRatio: | 6.1153 |
| dividendsPerShare: | 2.8000 |
| priceEarningsRatio: | 19.3992 |
| netEarningsPerShare: | 5.7193 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 106675.0000 |
| cash: | 6841.0000 |
| currentAssets: | 32168.0000 |
| fixedAssets: | 74507.0000 |
| liabilities: | 25694.0000 |
| totalLiabilitiesEquity: | 106675.0000 |
| totalShareholdersEquity: | 37635.0000 |
| property: | 23051.0000 |
| intangibleAssets: | 18011.0000 |
| longTermInvestments: | 252.0000 |
| inventories: | 6358.0000 |
| accountsReceivable: | 10349.0000 |
| accountsPayable: | 3922.0000 |
| liabilitiesTotal: | 69040.0000 |
| longTermDebt: | 33683.0000 |
| shortTermDebt: | 1372.0000 |
| minorityInterests: | 54.0000 |
| commonStock: | 1788.0000 |
| sales: | 60115.0000 |
| depreciation: | 3844.0000 |
| netIncome: | 365.0000 |
| incomeInterest: | -781.0000 |
| investments: | 30531.0000 |
| incomeTaxes: | 1512.0000 |
| costGoodsSold: | 16126.0000 |
| grossProfit: | 43989.0000 |
| minorityInterestsProfit: | 12.0000 |
| cashFlow: | 13006.0000 |
| cashFlowInvesting: | -14083.0000 |
| cashFlowFinancing: | -4810.0000 |
| cashFlowTotal: | -5864.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 35.2801 |
| debtEquityRatio: | 0.9314 |
| liquidityI: | 0.2662 |
| liquidityII: | 0.6690 |
| netMargin: | 0.6072 |
| grossMargin: | 73.1747 |
| cashFlowMargin: | 21.6352 |
| ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 5.0193 |
| preTaxROA: | 1.7708 |
| roe: | 0.9698 |
| roa: | 0.3422 |
| netIncomeGrowth: | -97.4861 |
| revenuesGrowth: | 1.4034 |
| taxExpenseRate: | 80.0424 |
| equityTurnover: | 1.5973 |
| epsBasic: | 0.1400 |
| epsDiluted: | 0.1400 |
| epsBasicGrowth: | -97.5567 |
| shareCapital: | 1788.0000 |
| incomeBeforeTaxes: | 1889.0000 |
| priceEarningsRatioCompany: | 778.7143 |
| priceCashFlowRatio: | 21.2293 |
| dividendYield: | 2.7151 |
| bookValuePerShare: | 14.8600 |
| marketCap: | 276108834925.4400 |
| earningsYield: | 0.1284 |
| pegRatio: | -7.9822 |
| cashFlowPerShare: | 5.1353 |
| netAssetsPerShare: | 14.8813 |
| priceBookValueRatio: | 7.3365 |
| dividendsPerShare: | 2.9600 |
| priceEarningsRatio: | 756.4626 |
| netEarningsPerShare: | 0.1441 |
| currency: | USD |
| year: | 2024 |
| priceEarningsRatioCompany: | 728.5714 |
| priceCashFlowRatio: | 19.8623 |
| dividendYield: | 2.9020 |
| bookValuePerShare: | 14.8600 |
| marketCap: | 258022835790.0000 |
| earningsYield: | 0.1373 |
| pegRatio: | -7.4682 |
| cashFlowPerShare: | 5.1353 |
| netAssetsPerShare: | 14.8600 |
| priceBookValueRatio: | 6.8641 |
| priceEarningsRatio: | 707.7525 |
| netEarningsPerShare: | 0.1441 |
| currency: | USD |
